Literature DB >> 7783891

Cardiac arrest following use of sumatriptan.

K M Kelly1.   

Abstract

I report a 35-year-old woman with occult coronary artery disease who experienced cardiac arrest within minutes after receiving a first-time dose of subcutaneous sumatriptan for migraine. The patient was resuscitated, and subsequent serial cardiac enzymes indicated myocardial infarction. Because sumatriptan can cause coronary artery vasospasm, patients with significant risk factors for coronary artery disease should be carefully evaluated for cardiovascular disease prior to the use of sumatriptan.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783891     DOI: 10.1212/wnl.45.6.1211

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Long-term use of daily sumatriptan injections in severe drug-resistant chronic cluster headache.

Authors:  Massimo Leone; Alberto Proietti Cecchini
Journal:  Neurology       Date:  2015-10-16       Impact factor: 9.910

2.  A case of myocardial infarction with sumatriptan use.

Authors:  E Erbilen; H Ozhan; R Akdemir; M Yazici
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

Review 3.  Sumatriptan. An updated review of its use in migraine.

Authors:  C M Perry; A Markham
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

4.  Preventive agents for migraine: focus on the antiepileptic drugs.

Authors:  R Shahien; K Beiruti
Journal:  J Cent Nerv Syst Dis       Date:  2012-02-26

5.  Thyrotoxicosis, sumatriptan and coronary artery spasm.

Authors:  Sukhbinder Bassi; Raj Amersey; Robert Henderson; G Keith Morris
Journal:  J R Soc Med       Date:  2004-06       Impact factor: 18.000

6.  Triptans and troponin: a case report.

Authors:  Claudia R Weder; Markus Schneemann
Journal:  Orphanet J Rare Dis       Date:  2009-06-18       Impact factor: 4.123

7.  Vasospasm induced myocardial ischaemia secondary to sumatriptan use.

Authors:  Kenneth Okonkwo; Utkarsh Ojha
Journal:  BMJ Case Rep       Date:  2020-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.